ALMR

26.6307.15%
NJ

Nicholas J. Naclerio

Independent Director

Dr. Nicholas J. Naclerio, also known as Nick, Ph.D., is Independent Director of Alamar Biosciences, Inc. from May 2020. He is Director of PrivaPath Diagnostics Limited from May 5, 2020. He is Chairman of the Board at Stilla Technologies SA. He was Director of baebies inc. from June 30, 2016 to 2025. He serves as Director at Pattern Bioscience, Inc. He serves as the Founding Partner & Founder at Illumina Ventures since joining in April 2016 and serves as its Managing Partner. Dr. Naclerio serves as a Director at DNA Script SAS. He serves on the board of Klaris Corp. He had been the Senior Vice President of Corporate and Venture Development at Illumina Inc from July 2010 to 2016. Dr. Naclerio served as General Manager of Enterprise Informatics at Illumina Inc until July 2015. He joined Illumina Inc in 2010 and was responsible for all corporate business development activities, including strategic planning, licensing, corporate partnerships and acquisitions. In addition, he led Illumina’s Enterprise Informatics business which enables the storage, analysis, understanding and sharing of genomic and phenotypic information. Prior to joining Illumina, he co-founded and served as the Executive Chairman of Quanterix Corporation. He is Director at Serimmune Inc. Dr. Naclerio served as the Chief Executive Officer, Director and President of Parallele Bioscience, Inc. He joined ParAllele with a combination of commercial and operations management skills for startup ventures and strategic perspective. Dr. Naclerio also served as a Vice President and General Manager of the BioChip Systems business unit at Motorola, Inc. since June 1999. Most recently, he served as an independent Strategic Consultant to several life science companies and venture capital groups, conducting projects focused on business development, marketing strategies, corporate partnerships, operational restructuring and fund-raising. He founded Motorola's Life Science business unit and led it through the commercial launch of its CodeLink microarray platform. In his career he was an Assistant Director at the Defense Advanced Research Projects Agency (DARPA) and was responsible for investing in dozens of successful entrepreneurial companies. He was a Senior Vice President and Chief Business Officer at Zyomyx Inc. He also held leadership roles at Motorola Ventures and the U.S. Air Force. He serves as Board Observer at Genome Medical Holding Co (formerly known as Genome Medical, Inc.). since November 2021 and served as Director until November 2021. Dr. Naclerio served as a Director of Boreal Genomics Inc. He has served on the Boards of several other life science companies including SEMATECH, Orchid BioScience and Clinical Microsensors and The SNP Consortium. Previously, he served as Executive Chairman of True Materials. Dr. Naclerio served as a Director of Genometrix, Inc. since February 1999. Mr. Naclerio received a B.S. (summa cum laude) in Electrical Engineering and Computer Science from Duke University, a Winston Churchill Fellowship in Materials Science to Cambridge University and a Ph.D. in Electrical Engineering from the University of Maryland College Park.

Positions